Welcome to Aptus Clinical

Aptus Clinical specialises in the provision of expert clinical research professionals. We partner with life science companies and academia in their quest to identify and develop valuable new medicines.

We have a passion for drug development and a belief in the power of collective knowledge. We understand the challenges our clients face in navigating the varied needs of payers, regulatory authorities and health economics and bring together individuals/teams with the experience, ethics and industry leading knowledge to help find solutions.

Our integrated network of clinical development professionals enables their pooled expertise to be shared to add real value & maximise the benefits to our clients.

To Learn More About Our Company Click Here

Our Services

We provide both strategic design input and operational delivery excellence through our flexible team of highly experienced drug development experts.

Our Networks

All of our experts have considerable experience in the clinical research arena and are able to bring immediate benefits to our client’s drug development projects. All have the skills to successfully navigate the many pitfalls of a challenging global environment, combined with the flexibility to seamlessly integrate into client teams and provide extensive insight into the effective delivery of drug development projects.

If you are a Pharma company or academic institution looking for strategic input to study design or need flexible and cost effective clinical research professionals to support the delivery of your clinical development projects then please get in touch

To Get In Touch Click Here

Aptus Latest News

Aptus Study Team leads AstraZeneca AZD5363 BEECH study to recruitment milestone

Led by a 5 strong clinical operations team from Aptus Clinical, the AZD5363 ‘BEECH’ study recently completed recruitment with a total of 110 patients randomised to this Phase 2b study examining the safety, tolerability and efficacy of AZD5363 when combined with Paclitaxel in Breast Cancer patients which is being conducted in 11 counties around the world.

Read More

Aptus Clinical signs Clinical Development Agreement with Taiwan based OBI Pharma

15th January 2015

We are pleased to announce that we have entered into an agreement with OBI Pharma to support their physicians and scientists in the design of a translational medicine study to support the development of their breast cancer vaccine OBI-822.

Read More

Aptus Clinical at BIO 2015 in Philadelphia

14th June 2015

Steve McConchie, Aptus Clinical CEO, will be at Bio 2015 in Philadelphia from the 15th to the 18th of June at the Pennsylvania Convention Centre. We would be delighted to meet up with new or existing customers at the meeting. Please get in touch via the conference partnering system or leave a message via the Contact Us page. We hope to see you there.